Sign inGet started

Newman Michael James

Insider CIK 1876315 · INDP CSO and Director, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
INDP Indaptus Therapeutics, Inc A Award2025-12-222025-12-2952,204$2.03 $106.0K101,074SEC↗
INDP Indaptus Therapeutics, Inc A Award deriv2024-10-092024-10-1075,000— $075,000SEC↗
INDP Indaptus Therapeutics, Inc A Award deriv2024-01-222024-01-2343,250— $043,250SEC↗
INDP Indaptus Therapeutics, Inc A Award deriv2023-01-182023-01-2043,250— $043,250SEC↗
INDP Indaptus Therapeutics, Inc S Sale2022-02-012022-02-0214,130$5.00 $70.7K1,368,356SEC↗
INDP Indaptus Therapeutics, Inc S Sale2022-01-312022-02-025,870$5.00 $29.4K1,382,486SEC↗
INDP Indaptus Therapeutics, Inc A Award deriv2022-01-262022-01-2843,350— $043,350SEC↗
INDP Indaptus Therapeutics, Inc A Award deriv2021-08-042021-08-06290,000— $0290,000SEC↗